Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Glucose 5% infusion 50ml Viaflex bags
0902021G0BBAGBG
|
Baxter glucose | Glucose | Nutrition and Blood | 1 |
|
Glucose 50% solution for infusion 50ml vials
0902021G0AAAQAQ
|
Glucose (Parenteral) | Glucose | Nutrition and Blood | 1 |
|
Glutafin gluten free biscuits
0913461J0BBAEAA
|
Glutafin specialist food replacer OTC/disc sweet biscuits | Specialist food replacer OTC/disc sweet biscuits (0913461) | Nutrition and Blood | 1 |
|
Glutafin gluten free pasta spirals
0913461F0BDADAC
|
Glutafin specialist food replacer OTC pasta | Specialist food replacer OTC or disc pasta (0913461) | Nutrition and Blood | 1 |
|
Gluten free biscuits
0904010A0AABFBF
|
Gluten free /wheat free (biscuits) | Gluten free/wheat free biscuits | Nutrition and Blood | 1 |
|
Gluten free bread
0904010H0AAAAAA
|
Gluten free (bread) | Gluten free breads | Nutrition and Blood | 1 |
|
Glutenex gluten free white bread mix
0913461C0BDAAAE
|
Glutenex specialist food replacer OTC/disc flour type mix | Specialist food replacer OTC/disc flour type mixes (0913461) | Nutrition and Blood | 1 |
|
Glyceryl trinitrate 0.02% ointment
0107040A0AAAJAJ
|
Glyceryl trinitrate (Haemorrhoids) | Glyceryl trinitrate | Gastro-Intestinal System | 1 |
|
Glyceryl trinitrate 2% ointment
0206010F0AAAFAF
|
Glyceryl trinitrate (Angina) | Glyceryl trinitrate | Cardiovascular System | 1 |
|
Glycopyrronium bromide 0.5% in Generic Unguentum M cream
1312000G0AABIBI
|
Glycopyrronium (Topical) | Glycopyrronium bromide | Skin | 1 |
|
Glycopyrronium bromide 2% cream
1312000G0AAANAN
|
Glycopyrronium (Topical) | Glycopyrronium bromide | Skin | 1 |
|
Glycopyrronium bromide 4% cream
1312000G0AAATAT
|
Glycopyrronium (Topical) | Glycopyrronium bromide | Skin | 1 |
|
Glycopyrronium bromide 4mg/5ml oral solution
0102000L0AAAVAV
|
Glycopyrronium bromide (Oral) | Glycopyrronium bromide | Gastro-Intestinal System | 1 |
|
Glycopyrronium bromide powder for solution for iontophoresis
1312000G0AAAAAA
|
Glycopyrronium (Topical) | Glycopyrronium bromide | Skin | 1 |
|
Gonal-f 900units/1.44ml inj pre-filled pens
0605010I0BBAQAW
|
Gonal-F | Follitropin alfa | Endocrine System | 1 |
|
GoResp Digihaler 320microg/dose / 9microg/dose dry pdr inh
0302000K0BKABAU
|
GoResp Digihaler | Budesonide | Respiratory System | 1 |
|
Gramegran 50mg tablets
0407041T0BFAAAF
|
Gramegran | Sumatriptan succinate | Central Nervous System | 1 |
|
Granisetron 3mg/3ml solution for injection ampoules
0406000M0AAAAAA
|
Granisetron hydrochloride | Granisetron hydrochloride | Central Nervous System | 1 |
|
Griseofulvin 250mg/5ml oral suspension
0502050B0AAARAR
|
Griseofulvin (Systemic) | Griseofulvin | Infections | 1 |
|
Guaifenesin 100mg/5ml / Pseudoephedrine 30mg/5ml soln SF
0309020G0AAATAT
|
Guaifenesin (Expectorant/Demulcents) | Guaifenesin | Respiratory System | 1 |
|
Guaifenesin 50mg/5ml oral solution sugar free
0309020G0AAANAN
|
Guaifenesin (Expectorant/Demulcents) | Guaifenesin | Respiratory System | 1 |
|
Guaifenesin 600mg modified-release tablets
1002020L0AAACAC
|
Guaifenesin (Systemic) | Guaifenesin | Musculoskeletal and Joint Diseases | 1 |
|
GyneFix intrauterine contraceptive device
21040000245
|
GyneFix intrauterine contraceptive device | Contraceptive Devices | Appliances | 1 |
|
Gypsona bandage 10cm x 2.7m
20020200532
|
Gypsona bandage 10cm x 2.7m | Arm Sling/Bandages | Dressings | 1 |
|
Haddenham Doktus class 3 (34-46mmHg) armsleeve extra wide
21270000424
|
Haddenham Doktus class 3 (34-46mmHg) armsleeve extra wide | Lymphoedema Garments | Appliances | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.